Search for: "McNEIL v. UNITED STATES" Results 161 - 172 of 172
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
25 Jan 2008, 1:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]Highlights this week included:Chinese company Zhongyi Electronic sues Microsoft for alleged patent infringement relating to technology that converts Roman characters to Chinese characters: (Jurist), (China Hearsay), (IP Dragon),US Patent reform and surrounding controversy: general commentary and opinions: (Patent Baristas), (IPBiz), (IPBiz), (IPBiz), (Patent … [read post]
20 Oct 2010, 3:51 pm
http://tinyurl.com/2dcd3qk New Rules for Employees' Mobile Device Privacy - http://tinyurl.com/2ewjnal Ongoing Compliance Assessments: FCPA, UK Bribery Act and OCED Best Practices - http://tinyurl.com/28f7k9s Social-Media Policies for Law Firms - http://tinyurl.com/2dpszh2 The Return Line in e-Discovery - http://tinyurl.com/232zwn9 United States: New York State Court Decision Potentially Undermines Effect of Commonplace Arbitration Clauses -… [read post]
2 May 2008, 7:00 am
: (Spicy IP), Ultracet (Tramadol) – Barr and Caraco win summary judgment that Ortho-McNeil’s formulation patent on Ultracet is invalid: (Orange Book Blog), Xopenex (Levosalbutamol) – US: Sepracor, Breath settle Xopenex patent fight: (IP Law360), (GenericsWeb), Africa African copyright & access to knowledge (ACA2K) project launched: (Michael Geist), (Afro-IP), Seven reasons why Prof Odek should be the next WIPO DG: (Afro-IP), … [read post]
11 Jul 2008, 4:30 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: ACTA continues to be discussed and debated: (Michael Geist), (Intellectual Property Watch), (Public Knowledge),  (Techdirt), (Managing Intellectual Property), (Public Knowledge), (Public Knowledge), (Public Knowledge), Apotex challenge to Acular LS patent barred by res judicata: Roche Palo Alto & Allergan v Apotex:… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
23 Dec 2023, 7:16 pm by admin
Not only was the statement wrong in 1993, when the Supreme Court decided the famous Daubert case, it was wrong 20 years later, in 2013, when the United States Food and Drug Administration (FDA) approved  Diclegis, a combination of doxylamine succinate and pyridoxine hydrochloride, the essential ingredients in Bendectin, for sale in the United States, for pregnant women experiencing nausea and vomiting.[16] The return of Bendectin to the market, although under… [read post]
1 Mar 2007, 4:57 am by Ricky E. Bagolie
If one class of proteins has more activity than the other class, an abnormal state exists and a person becomes either at risk of excessive clotting (thrombosis) or excessive bleeding. [read post]
15 Mar 2007, 2:12 am by Dariusz Czuchaj
Geographical Distribution of Parties Though the geographical spread of named parties to WIPO UDRP cases (gTLD and ccTLD) reached 137 countries at the end of December 2006, the most frequently named party country both for complainants and for respondents continued to be the United States of America (USA). [read post]
6 Mar 2016, 4:00 am by Administrator
À cet égard, il y a lieu de retenir les principes généraux énoncés dans la cause américaine United States of America v. [read post]